Cargando…
Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure
Tolvaptan (TLV) is a diuretic agent administrated for heart failure (HF) only in Japan. Many clinical findings have been obtained from the accumulation of clinical experience, and the administration of TLV reportedly avoids causing a reduction in the renal function. In addition, TLV has been reporte...
Autores principales: | Kiuchi, Shunsuke, Ikeda, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421149/ https://www.ncbi.nlm.nih.gov/pubmed/30210135 http://dx.doi.org/10.2169/internalmedicine.1697-18 |
Ejemplares similares
-
Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients
por: Kiuchi, Shunsuke, et al.
Publicado: (2021) -
Early initiation of tolvaptan is associated with early discharge in patients with heart failure regardless of age
por: Kiuchi, Shunsuke, et al.
Publicado: (2022) -
Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011) -
Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016) -
Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients
por: Nodari, Savina, et al.
Publicado: (2010)